Stay updated on ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial
Sign up to get notified when there's something new on the ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial page.

Latest updates to the ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedVersion 86 adds a new 'Study Status' section to the history and removes the prior funding-status notice.SummaryDifference0.5%

- Check20 days agoChange DetectedAdded a site-wide notice about government funding status and NIH Clinical Center operations; updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check28 days agoChange DetectedUI updates on the Record History page introduce a glossary toggle, color-coded change indicators (green for additions and red for deletions), and a new site revision note showing v3.4.0 replacing v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedRevision v3.3.4 was added to the record history and Revision v3.3.3 was removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision: v3.3.3 was added to the page history, while HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedThe history now shows an added Revision: v3.3.2 and a deleted Revision: v3.3.1 for the page.SummaryDifference0.0%

Stay in the know with updates to ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial page.